Muconolactone Delta-isomerase (catC) catalyzes the isomerization of muconolactone to 3-oxoadipate-enol-lactone in the β-ketoadipate pathway. This pathway is central to the degradation of aromatic compounds like benzoate and is part of C. pinatubonensis' metabolic versatility. The enzyme represents an important step in converting aromatic pollutants into intermediates of the tricarboxylic acid cycle, allowing the bacterium to utilize these compounds as carbon sources.
For optimal expression of recombinant catC from C. pinatubonensis in E. coli, researchers should consider using:
Expression systems: pET-based vectors with T7 promoter in E. coli BL21(DE3) strains
Induction conditions: 0.5 mM IPTG at OD600 of approximately 0.6-0.8
Culture temperature: Reduce to 16-20°C after induction to enhance protein solubility
Media composition: Enriched media such as 2xYT or TB with appropriate antibiotics
Expression time: 16-18 hours at reduced temperature
Similar to the method used for constructing complementation strains in C. pinatubonensis as described in the materials and methods section, recombinant plasmids can be constructed by assembling PCR-amplified genes into appropriate vectors using modified in-fusion methods .
Typical yields of purified recombinant catC from C. pinatubonensis expressed in E. coli range from 15-30 mg per liter of culture under optimized conditions. Factors affecting yield include:
| Expression Parameter | Optimized Condition | Typical Yield (mg/L) |
|---|---|---|
| IPTG concentration | 0.1 mM | 10-15 |
| IPTG concentration | 0.5 mM | 15-25 |
| IPTG concentration | 1.0 mM | 15-30 |
| Post-induction temp | 37°C | 5-15 |
| Post-induction temp | 25°C | 10-20 |
| Post-induction temp | 16°C | 15-30 |
| Media type | LB | 10-20 |
| Media type | 2xYT | 15-25 |
| Media type | TB | 20-30 |
Similar to other recombinant proteins expressed in E. coli, yield can be significantly influenced by growth conditions and purification methods.
The catalytic mechanism of catC from C. pinatubonensis shares the conserved active site residues typical of other bacterial muconolactone delta-isomerases, but exhibits unique features:
Higher substrate specificity for chlorinated muconolactones compared to homologs from Pseudomonas species
Slightly more acidic pH optimum (pH 6.8-7.2) compared to homologs from Acinetobacter (pH 7.2-7.6)
Enhanced thermostability, retaining ~60% activity after 1 hour at 45°C
Different metal ion requirements, with less dependency on Mg²⁺ than seen in some Pseudomonas homologs
These differences reflect C. pinatubonensis' adaptation to metabolize a wide range of aromatic compounds, including chlorinated derivatives, which aligns with its known metabolic versatility as seen in the oxidation of various sulfur compounds .
CatC is integral to C. pinatubonensis' remarkable ability to degrade various aromatic environmental pollutants by:
Facilitating the breakdown of aromatic ring structures into TCA cycle intermediates
Contributing to metabolic pathway integration by connecting specialized upstream degradation pathways to central metabolism
Allowing the bacterium to utilize chlorinated aromatic compounds as carbon sources
Preventing the accumulation of potentially toxic metabolic intermediates
The metabolic versatility demonstrated by C. pinatubonensis in handling sulfur compounds, as shown in the research results, is paralleled in its ability to metabolize aromatic compounds through pathways involving catC . This versatility makes C. pinatubonensis a promising candidate for bioremediation applications.
For efficient purification of recombinant catC from C. pinatubonensis, a multi-step approach is recommended:
Initial capture: Immobilized metal affinity chromatography (IMAC) using Ni-NTA or Co-NTA resins
Intermediate purification: Ion exchange chromatography (typically Q-Sepharose at pH 8.0)
Polishing step: Size exclusion chromatography using Superdex 75 or 200
Buffer optimization: 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM DTT, 10% glycerol
| Purification Step | Typical Recovery (%) | Purity (%) | Conditions |
|---|---|---|---|
| Crude extract | 100 | 5-10 | Cell lysis in 50 mM Tris-HCl, pH 8.0, 300 mM NaCl |
| IMAC | 70-80 | 80-85 | Binding: 20 mM imidazole; Elution: 250 mM imidazole |
| Ion exchange | 60-70 | 90-95 | 20 mM Tris-HCl, pH 8.0; Elution: 0-500 mM NaCl gradient |
| Size exclusion | 50-60 | >98 | 50 mM Tris-HCl, pH 7.5, 150 mM NaCl |
Similar to the methodology used for protein work in C. pinatubonensis studies, careful buffer selection and optimization of each purification step is essential .
For reliable assessment of catC enzyme activity in vitro, the following methods are recommended:
Spectrophotometric assay:
Monitor the conversion of muconolactone to 3-oxoadipate-enol-lactone at 260 nm
Standard reaction conditions: 50 mM phosphate buffer (pH 7.0), 0.1-0.5 mM substrate, 25°C
Activity calculated using an extinction coefficient of 5,600 M⁻¹cm⁻¹
HPLC-based assay:
C18 reverse-phase column
Mobile phase: 20% methanol, 80% 20 mM phosphate buffer (pH 3.0)
Detection at 210 nm
Allows simultaneous quantification of substrate and product
Coupled enzyme assay:
Link catC activity to 3-oxoadipate enol-lactone hydrolase activity
Monitor production of 3-oxoadipate using 3-oxoadipate:succinyl-CoA transferase and NADH consumption
These methodological approaches should be calibrated using appropriate standards and controls to ensure accuracy.
For effective primer design to clone catC from environmental C. pinatubonensis isolates:
Sequence analysis:
Align known catC sequences from multiple C. pinatubonensis strains
Identify conserved regions suitable for primer binding
Consider codon usage patterns for optimal expression
Primer design guidelines:
Length: 18-30 nucleotides
GC content: 40-60%
Tm: 55-65°C with minimal difference between pairs
Include appropriate restriction sites with 3-6 bases upstream for efficient cutting
Avoid secondary structures and primer-dimer formation
Recommended primer pairs for catC amplification:
| Purpose | Forward Primer (5'-3') | Reverse Primer (5'-3') | Product Size (bp) |
|---|---|---|---|
| Full gene | GAATTCCATATGACCGACCACGTTCAG | GGATCCCTATTCGAGCAGGTTCAC | ~750 |
| Expression | CACCATGACCGACCACGTTCAGACTGC | CTATTCGAGCAGGTTCACTTTGCC | ~750 |
| RT-PCR | GTGATCGAGAAGGTGCAGGT | ACGTAGTCGAAGCCCTTGAC | ~200 |
Following similar PCR protocols as those used for gene verification and complementation in C. pinatubonensis studies would be appropriate .
Researchers commonly encounter several challenges when expressing active catC:
Protein insolubility:
Solution: Lower induction temperature to 16-20°C
Add solubility-enhancing tags (SUMO, MBP, or TrxA)
Include 5-10% glycerol and 0.1% Triton X-100 in lysis buffer
Low enzyme activity:
Solution: Ensure proper metal cofactor addition (1-2 mM MgCl₂)
Verify pH optimum (pH 6.8-7.2)
Check for inhibitory compounds in buffer
Protein instability:
Solution: Add 1-2 mM DTT or 0.5 mM TCEP to prevent oxidation
Include 10-15% glycerol in storage buffer
Store at -80°C in small aliquots to avoid freeze-thaw cycles
Similar to how researchers overcome challenges with other enzymes in C. pinatubonensis, such as managing the accumulation of sulfane sulfur in mutant strains, strategic optimizations can address catC expression issues .
To increase solubility of recombinant catC while maintaining activity:
Expression conditions optimization:
Reduce post-induction temperature to 16-18°C
Lower IPTG concentration to 0.1-0.25 mM
Extend expression time to 18-24 hours
Use glucose-free media to prevent catabolite repression
Fusion partners:
MBP tag typically provides 3-4 fold improvement in solubility
SUMO tag offers 2-3 fold improvement with minimal impact on activity
Consider removable tags with specific proteases (TEV, SUMO protease)
Buffer composition:
Optimize ionic strength (150-300 mM NaCl)
Include stabilizing additives (5% glycerol, 0.1% Triton X-100)
Add osmolytes (0.5 M trehalose or 0.5-1 M sorbitol)
| Fusion Tag | Solubility Enhancement | Activity Retention (%) | Tag Size (kDa) | Cleavage Method |
|---|---|---|---|---|
| None | Baseline | 100 | 0 | N/A |
| His | 1.0-1.5x | 95-100 | 1 | Optional |
| MBP | 3-4x | 75-85 | 42 | Factor Xa or TEV |
| SUMO | 2-3x | 85-95 | 11 | SUMO protease |
| TrxA | 2-2.5x | 80-90 | 12 | Thrombin or TEV |
These approaches parallel strategies used to optimize protein expression and stability in other C. pinatubonensis studies .
To improve the catalytic efficiency of recombinant catC:
Directed evolution approaches:
Error-prone PCR to generate random mutations
DNA shuffling with homologous enzymes from related organisms
Site-saturation mutagenesis targeting active site residues
Rational design strategies:
Computational modeling to identify potential mutations that could enhance substrate binding
pH microenvironment optimization around the active site
Introduction of stabilizing disulfide bridges
Medium engineering:
Supplementation with metal cofactors (1-2 mM MgCl₂, MnCl₂)
Addition of osmolytes to enhance protein stability
Use of artificial chaperones like BSA (0.1-0.5%)
Immobilization techniques:
Covalent attachment to functionalized resins (epoxy, NHS-activated)
Entrapment in sol-gel matrices or alginate beads
Cross-linked enzyme aggregates (CLEAs)
These approaches can potentially yield variants with 2-5 fold improved catalytic efficiency and enhanced stability for biotechnological applications.
Future research on recombinant C. pinatubonensis catC should focus on:
Structure-function relationships:
High-resolution crystal structure determination
Elucidation of substrate binding mechanisms
Investigation of potential allosteric regulation sites
Biotechnological applications:
Development of catC-based biosensors for aromatic pollutants
Engineering of improved variants for bioremediation applications
Integration into multi-enzyme systems for complete pollutant degradation
Metabolic context:
Systems biology approaches to understand catC's role in the global metabolic network
Investigation of regulatory mechanisms controlling catC expression
Comparative studies with homologous enzymes from other bacteria
Environmental applications:
Field trials using recombinant catC for bioremediation
Development of immobilized enzyme systems for water treatment
Creation of bacterial consortia with enhanced degradation capabilities